11-17387790-G-T
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4BP6BS1
The NM_000525.4(KCNJ11):c.302C>A(p.Ala101Asp) variant causes a missense change. The variant allele was found at a frequency of 0.000018 in 1,614,012 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000525.4 missense
Scores
Clinical Significance
Conservation
Publications
- diabetes mellitus, transient neonatal, 3Inheritance: AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
- monogenic diabetesInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- hyperinsulinemic hypoglycemia, familial, 2Inheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Myriad Women’s Health, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- diabetes mellitus, noninsulin-dependentInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- diabetes mellitus, permanent neonatal 2Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- maturity-onset diabetes of the young type 13Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- autosomal dominant hyperinsulinism due to Kir6.2 deficiencyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- DEND syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- intermediate DEND syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- maturity-onset diabetes of the youngInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- permanent neonatal diabetes mellitusInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- transient neonatal diabetes mellitusInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- autosomal recessive hyperinsulinism due to Kir6.2 deficiencyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- diazoxide-resistant focal hyperinsulinism due to Kir6.2 deficiencyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| KCNJ11 | NM_000525.4 | c.302C>A | p.Ala101Asp | missense_variant | Exon 1 of 1 | ENST00000339994.5 | NP_000516.3 | |
| KCNJ11 | NM_001166290.2 | c.41C>A | p.Ala14Asp | missense_variant | Exon 2 of 2 | NP_001159762.1 | ||
| KCNJ11 | NM_001377296.1 | c.41C>A | p.Ala14Asp | missense_variant | Exon 3 of 3 | NP_001364225.1 | ||
| KCNJ11 | NM_001377297.1 | c.41C>A | p.Ala14Asp | missense_variant | Exon 2 of 2 | NP_001364226.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152226Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000199 AC: 5AN: 250870 AF XY: 0.0000369 show subpopulations
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461786Hom.: 0 Cov.: 63 AF XY: 0.00000963 AC XY: 7AN XY: 727198 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000105 AC: 16AN: 152226Hom.: 0 Cov.: 33 AF XY: 0.0000941 AC XY: 7AN XY: 74360 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Hyperinsulinemic hypoglycemia, familial, 2;C4225365:Maturity-onset diabetes of the young type 13 Uncertain:1
The c.302C>A variant in KCNJ11 has previously been reported in an heterozygous state in an infant with congenital hyperinsulinism [PMID: 15562009] and it has been deposited in ClinVar [ClinVar ID: 552375] as Variant of Uncertain Significance. The c.302C>A variant is observed in 96 alleles (~0.016% MAF with 0 homozygotes) in population databases (gnomAD v2.1.1 and v3.1.2, TOPMed Freeze 8), suggesting it is not a common benign variant in the populations represented in those databases, which might include individuals with multifactorial endocrine system disorders. The c.302C>A variant in KCNJ11 is located in the extracellular domain of this 1-exongene, and predicted to replace an evolutionarily conserved alanine amino acid with aspartate at position 101 (p.(Ala101Asp). In silico predictions are not in favor of damaging effect for p.(Ala101Asp) [CADD v1.6 = 18.2, REVEL = 0.467]; however, there are no functional studies to support or refute these predictions. Based on available evidence this c.302C>A p.(Ala101Asp) variant identified in KCNJ11 is classified as a Variant of Uncertain Significance. -
Type 2 diabetes mellitus;C1864623:Diabetes mellitus, transient neonatal, 3;C2931833:Hyperinsulinemic hypoglycemia, familial, 2;C4225365:Maturity-onset diabetes of the young type 13;C5394296:Diabetes mellitus, permanent neonatal 2 Uncertain:1
- -
Maturity onset diabetes mellitus in young Uncertain:1
Mutations in KCNJ11 gene can cause decreased production and secretion of insulin. This can lead to MODY which may be responsive to oral sulfonylureas. It is also associated with with Neonatal Diabetes. However, no sufficient evidence is found to ascertain the role of rs1014454531 variant in MODY yet. -
Diabetes mellitus, transient neonatal, 3;C2931833:Hyperinsulinemic hypoglycemia, familial, 2;C5393570:Permanent neonatal diabetes mellitus 1 Uncertain:1
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
not provided Benign:1
See Variant Classification Assertion Criteria. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at